Production of latent collagenase by human umbilical vein endothelial cells in response to angiogenic preparations.
Three preparations known to be angiogenic in vivo and which stimulate production of latent collagenase by cultured bovine capillary endothelial (BCE) cells were tested for their ability to stimulate production of latent collagenase by cultured human umbilical vein endothelial (HUVE) cells. Bovine retinal extract and murine adipocyte-conditioned medium had no effect on production of latent collagenase by HUVE cells at concentrations that were effective in stimulating production of latent collagenase by BCE cells. However, with higher concentrations of bovine retinal extract, production of latent collagenase by HUVE cells was stimulated. Human hepatoma cell sonicate stimulated production of latent collagenase by HUVE cells in a dose-dependent manner. The concentration of human hepatoma cell sonicate which stimulated production of latent collagenase by HUVE cells was lower than the concentration that was effective for the stimulation of production of latent collagenase by BCE cells. Plasminogen activator production by HUVE cells was unaffected by human hepatoma cell sonicate. Varying the concentration of serum in HUVE cultures did not affect the stimulation of latent collagenase production by human hepatoma cell sonicate, suggesting that serum components neither block nor stimulate the action of the collagenase-inducing factor. Although human hepatoma cell sonicate is reported to stimulate endothelial cell multiplication, purified and partially purified endothelial cell mitogens had no effect on production of latent collagenase. Thus, at least two preparations which contain angiogenic activity will stimulate production of latent collagenase by HUVE cells.
Moscatelli
D A
DA
Rifkin
D B
DB
Jaffe
E A
EA
D000273:Adipose Tissue / Q000166:cytology; D043925:Angiogenesis Inducing Agents / Q000494:pharmacology*; D001769:Blood; D006528:Carcinoma, Hepatocellular; D002470:Cell Survival; D002478:Cells, Cultured; D004727:Endothelium / Q000166:cytology / Q000201:enzymology*; D004790:Enzyme Induction; D004815:Epidermal Growth Factor / Q000494:pharmacology; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D006133:Growth Substances / Q000494:pharmacology*; D006801:Humans; D008113:Liver Neoplasms; D003012:Microbial Collagenase / Q000096:biosynthesis*; D008934:Mitogens / Q000494:pharmacology; D010960:Plasminogen Activators / Q000096:biosynthesis; D012160:Retina; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014020:Tissue Extracts / Q000494:pharmacology; D014471:Umbilical Veins / Q000166:cytology / Q000201:enzymology*
D043925:Angiogenesis Inducing Agents; D006133:Growth Substances; D008934:Mitogens; D014020:Tissue Extracts; D005346:Fibroblast Growth Factors; D004815:Epidermal Growth Factor; D010960:Plasminogen Activators; D003012:Microbial Collagenase; D013755:Tetradecanoylphorbol Acetate